Researchers Use GMO Mosquitoes to Vaccinate Humans in NIH-Funded Malaria Study

Contact Your Elected Officials
The Defender: Children's Health Defense News & Views

The National Institutes of Health funded a malaria vaccine trial study that used genetically modified mosquitoes to vaccinate humans. The Bill & Melinda Gates Foundation has close ties to the research.

The National Institutes of Health (NIH) funded a malaria vaccine trial study that used genetically modified (GM) mosquitoes to vaccinate humans.

team of researchers at the University of Washington conducted the study, which was published in the Science Translational Medicine journal.

The study involved 26 participants who received three to five “jabs” — or bites from a small box containing 200 GM mosquitoes — over a 30-day period.

Sanaria, a company funded in part by the Bill & Melinda Gates Foundation (BMGF), is closely connected to the research, and the researchers involved in the trial use a gene-editing technology heavily promoted by Bill Gates.

Genetically modified mosquitoes used as ‘flying syringes’

The trial used malaria-causing Plasmodium mosquitoes that were genetically modified to avoid causing sickness in humans to infect participants with a “minor” version of malaria — insufficient to cause severe illness, but enough to make the humans create antibodies.

Dr. Sean Murphy, lead author of the study, told NPR, “We use the mosquitoes like they’re 1,000 small flying syringes.”

Despite the publicity generated by this study, however, results appear to have been mixed.

Of the 14 trial participants exposed to malaria, seven contracted the disease. For the remaining seven, the protection conferred by the vaccine did not last more than a few months and eventually dissipated.

According to the study:

“Half of the individuals in each vaccine group did not develop detectable P. falciparum infection, and a subset of these individuals was subjected to a second [Controlled Human Malaria Infection] 6 months later and remained partially protected.”

According to the Centers for Disease Control and Prevention (CDC), “infections caused by P. falciparum are the most likely to progress to severe, potentially fatal forms” of malaria.

Adverse reactions in trial participants reportedly were “what one would expect after getting bit by hundreds of mosquitoes and nothing more.”

For example, trial participant Carolina Reid told NPR her entire forearm “swelled and blistered.”

Despite the study’s mixed results, the researchers claimed the “results support further development of genetically attenuated sporozoites as potential malaria vaccines.”

The researchers suggested several reasons for using live mosquitoes rather than a vaccine that could be delivered via a syringe, including that the use of live insects made sense, as the P. falciparum parasite quickly matures inside the mosquito.

In addition, the process of developing a version of the parasite that could be delivered via a syringe was described as “costly and time consuming.”

Nevertheless, according to Murphy the study will not be used for the mass vaccination of humans. However, the researchers involved in the trial said they believe the approach they used can eventually result in the development of a “substantially more effective” malaria vaccine.

By Michael Nevradakis, Ph.D.

Read Full Article on ChildrensHealthDefense.org

Children's Health Defense
Children's Health Defensehttps://childrenshealthdefense.org/
Children's Health Defense works to end childhood health epidemics by exposing causes, eliminating harmful exposures; seeking justice for the injured and establishing safeguards.

James Franklin’s contract fallout

Penn State’s decision to fire head coach James Franklin after a disappointing 22–21 home loss to Northwestern will cost an estimated $56 million buyout. 

Trump’s Middle East Trip Led to Historic Breakthroughs

Trump’s bold, unconventional strategy helped end the Israel-Hamas war and set the stage for a more stable, prosperous Middle East.

Pretending Really Hard

The world is real and so are its problems, too. Reality is the enemy of liberals, even though they are pretending, really hard, that it is not.

Trump 2.0’s Eurasian Balancing Act Has Failed

Trump's Eurasian balancing act has failed due to his arrogant and aggressive approach towards all three countries.

Should Palestinian clans rebelling against Hamas be given Gaza?

Hamas’s October 7 attack exposed its violent ideology, showing cruelty toward its enemies and also against the Palestinian people it claims to defend.

Trump, Patel Confirm FBI Special Agents Will Get Paid During Shutdown

FBI special agents will receive their paychecks despite the government shutdown, according to President Donald Trump and FBI Director Kash Patel.

Trump Admin Withholds $41 Million From California Over English-Language Trucking Rules

Trump admin withholds $40.6M in California transportation funds, citing failure to meet federal English proficiency rules for truck drivers.

An Inconvenient Study – Feature Film

Journalist Del Bigtree challenged a top infectious disease expert in 2016 to a vaxxed vs. unvaxxed study. The long-hidden results are finally revealed.

Federal Judge Temporarily Blocks Trump Admin’s Shutdown-Related Layoffs

A federal judge on Oct. 15 temporarily blocked President Donald Trump’s plan to lay off certain federal employees during the government shutdown. 

Trump Posthumously Awards Charlie Kirk the Presidential Medal of Freedom

President Trump posthumously awarded Charlie Kirk the Presidential Medal of Freedom in the White House Rose Garden on Oct 14, Charlie's birthday.

Trump Names Longtime Adviser Dan Scavino to Key Personnel Position

One of President Trump’s longtime advisers, Dan Scavino, is going to be in charge of selecting and appointing key positions within the executive branch.

First Lady’s Effort Helped Reunite 8 War-Displaced Children With Their Families

First lady Melania Trump said 8 children impacted by the fighting between Ukraine and Russia were reunited with their families on Oct. 9.

Trump to Impose New 100 Percent Tariff on China on Nov. 1

President Trump said that the US will impose an additional 100 percent tariffs on Chinese goods and export controls on critical software starting on Nov. 1.
spot_img

Related Articles

Popular Categories

MAGA Business Central